TP53 and cancer: Despite the development of cellular investigation technologies like The Cancer Genome Atlas, next-sequence generation, cut and run, single-cell RNA sequencing demonstrated receptor tyrosine kinase (RTK)/RAS, P53 gene mutation, and their role in carcinogenesis and tumor development, still cancer remains a mystery of science, and not every mutation leads to cancer initiation (Imperial et al., 2019).